These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14041945)

  • 1. [The syndrome of lipodystrophy, hepatic steatosis and resistant diabetes (with other associated changes)].
    JIMENEZ-DIAZ C; RODRIGUEZ-MINON JL; ARRIETA F
    Rev Iber Endocrinol; 1963; 10():143-7. PubMed ID: 14041945
    [No Abstract]   [Full Text] [Related]  

  • 2. [The lipodystrophy-hepatic-steatosis-resistant diabetes syndrome (with other associated changes)].
    JIMENEZ DIAZ C; RODRIGUEZ-MINON JL; ARRIETA F
    Rev Clin Esp; 1962 Jul; 86():9-13. PubMed ID: 13964659
    [No Abstract]   [Full Text] [Related]  

  • 3. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.
    Caux F; Dubosclard E; Lascols O; Buendia B; Chazouillères O; Cohen A; Courvalin JC; Laroche L; Capeau J; Vigouroux C; Christin-Maitre S
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1006-13. PubMed ID: 12629077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipohistiodiaresis: a syndrome of lipodystrophy universalis, accelerated growth, lipemia, hepatic cirrhosis, and insulin-resistant diabetes without ketosis.
    HANSEN AE; McQUARRIE I; ZIEGLER MR
    J Lancet; 1961 Dec; 81():533-41. PubMed ID: 13904403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)].
    Ongolo-Zogo P; Nkodo Mbia N; Mvogo Minkala TL; Biwole Sida M; Kouanfack C; Nko Amvene S
    Bull Soc Pathol Exot; 2012 Dec; 105(5):353-60. PubMed ID: 22886433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities.
    Akinci B; Koseoglu FD; Onay H; Yavuz S; Altay C; Simsir IY; Ozisik S; Demir L; Korkut M; Yilmaz N; Ozen S; Akinci G; Atik T; Calan M; Secil M; Comlekci A; Demir T
    Metabolism; 2015 Sep; 64(9):1086-95. PubMed ID: 26139569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONGENITAL LIPODYSTROPHIC DIABETES WITH ACANTHOSIS NIGRICANS: THE SEIP-LAWRENCE SYNDROME.
    REED WB; DEXTER R; CORLEY C; FISH C
    Arch Dermatol; 1965 Apr; 91():326-34. PubMed ID: 14275494
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.
    Lüdtke A; Genschel J; Brabant G; Bauditz J; Taupitz M; Koch M; Wermke W; Worman HJ; Schmidt HH
    Am J Gastroenterol; 2005 Oct; 100(10):2218-24. PubMed ID: 16181372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
    Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
    Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of fat redistribution, insulin resistance and hepatic fatty infiltration in HIV-associated lipodystrophy syndrome by pioglitazone: a case report.
    Prasithsirikul W; Bunnag P
    J Med Assoc Thai; 2004 Feb; 87(2):166-72. PubMed ID: 15061300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of seipin in adipose tissue rescues lipodystrophy, hepatic steatosis and insulin resistance in seipin null mice.
    Gao M; Wang M; Guo X; Qiu X; Liu L; Liao J; Liu J; Lu G; Wang Y; Liu G
    Biochem Biophys Res Commun; 2015 May; 460(2):143-50. PubMed ID: 25757906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
    Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
    Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
    Cardona-Hernández R; Suárez-Ortega L; Torres M
    An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.
    Sulyok M; Makara M; Rupnik Z; Ferenci T; Újhelyi E; Kormos L; Gerlei Z; Szlávik J; Horváth G; Vályi-Nagy I
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):679-85. PubMed ID: 25923943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice.
    Abulizi A; Perry RJ; Camporez JPG; Jurczak MJ; Petersen KF; Aspichueta P; Shulman GI
    FASEB J; 2017 Jul; 31(7):2916-2924. PubMed ID: 28330852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis, insulin resistance, and adipose tissue disorders.
    Garg A; Misra A
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3019-22. PubMed ID: 12107193
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
    AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.